Literature DB >> 8380795

Purification and characterization of fibroblast-activating factor isolated from Porphyromonas gingivalis W50.

J Mihara1, S C Holt.   

Abstract

A 24-kDa polypeptide which activated the incorporation of [3H]thymidine into human fibroblasts was isolated from the outer membrane vesicles of Porphyromonas gingivalis W50. This polypeptide, named fibroblast activating factor (FAF), was isolated by 3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-propane-sulfonate (CHAPS) detergent extraction and purified by DEAE ion-exchange chromatography and preparative isoelectric focusing. Purified FAF (100 ng of protein per ml) caused a 400% increase in [3H]thymidine incorporation into human gingival fibroblasts (HGFs) compared with results for controls. FAF was characterized as (i) a polypeptide with molecular masses of 24 kDa when heated at 100 degrees C for 5 min and 44 kDa when unheated, (ii) heat sensitive but not affected by selected reducing reagents, and (iii) possessing slight phosphatase activity. N'-terminal sequence analysis revealed no homology with P. gingivalis peptides or with any host-derived growth factors. These data suggest that FAF functions as a significant virulence factor which in vivo is capable of modulating homeostasis in local connective tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380795      PMCID: PMC302768          DOI: 10.1128/iai.61.2.588-595.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Proteases stimulate proliferation of human fibroblasts.

Authors:  P Pohjanpelto
Journal:  J Cell Physiol       Date:  1977-06       Impact factor: 6.384

2.  Effect of proteases on activation of resting chick embryo fibroblasts and on cell surface proteins.

Authors:  P M Blumberg; P W Robbins
Journal:  Cell       Date:  1975-10       Impact factor: 41.582

3.  Bacterial lipopolysaccharide potentiates gamma interferon-induced cytotoxicity for normal mouse and rat fibroblasts.

Authors:  R Dijkmans; J Van Damme; F Cornette; H Heremans; A Billiau
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Mitogenicity of thrombin and surface alterations on mouse splenocytes.

Authors:  L B Chen; N N Teng; J M Buchanan
Journal:  Exp Cell Res       Date:  1976-08       Impact factor: 3.905

Review 5.  Biological activities of outer membrane vesicles.

Authors:  D Mayrand; D Grenier
Journal:  Can J Microbiol       Date:  1989-06       Impact factor: 2.419

Review 6.  Subgingival microflora and periodontal disease.

Authors:  J Slots
Journal:  J Clin Periodontol       Date:  1979-10       Impact factor: 8.728

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Taxonomy, virulence and epidemiology of black-pigmented Bacteroides species in relation to oral infections.

Authors:  T J van Steenbergen; A J van Winkelhoff; U van der Velden; J de Graaff
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

9.  The expression and function of a Bacteroides gingivalis hemagglutinin gene in Escherichia coli.

Authors:  A Progulske-Fox; S Tumwasorn; S C Holt
Journal:  Oral Microbiol Immunol       Date:  1989-09

10.  Suppression of fibroblast growth by Bacteroides gingivalis endotoxin is not reduced by serum lipoproteins.

Authors:  D L Layman; L A Landreneau
Journal:  J Periodontol       Date:  1989-05       Impact factor: 6.993

View more
  11 in total

1.  Modulation of growth and function of human gingival fibroblasts by fibroblast-activating factor derived from Porphyromonas gingivalis W50.

Authors:  J Mihara; Y Miyazawa; S C Holt
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

2.  Role of Porphyromonas gingivalis-derived fibroblast-activating factor in bone resorption.

Authors:  J Mihara; T Yoneda; S C Holt
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Cystalysin, a 46-kilodalton cysteine desulfhydrase from Treponema denticola, with hemolytic and hemoxidative activities.

Authors:  L Chu; J L Ebersole; G P Kurzban; S C Holt
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  A novel approach for detecting an immunodominant antigen of Porphyromonas gingivalis in diagnosis of adult periodontitis.

Authors:  T Kawai; H O Ito; N Sakato; H Okada
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Immunobiological activities of a 55-kilodalton cell surface protein of Prevotella intermedia ATCC 25611.

Authors:  K Matsushita; S Nagaoka; R Arakaki; Y Kawabata; K Iki; M Kawagoe; H Takada
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 6.  Metal uptake in host-pathogen interactions: role of iron in Porphyromonas gingivalis interactions with host organisms.

Authors:  Janina P Lewis
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

7.  Species specificity, surface exposure, protein expression, immunogenicity, and participation in biofilm formation of Porphyromonas gingivalis HmuY.

Authors:  Teresa Olczak; Halina Wójtowicz; Justyna Ciuraszkiewicz; Mariusz Olczak
Journal:  BMC Microbiol       Date:  2010-05-04       Impact factor: 3.605

8.  Porphyromonas gingivalis HmuY and HmuR: further characterization of a novel mechanism of heme utilization.

Authors:  Teresa Olczak; Aneta Sroka; Jan Potempa; Mariusz Olczak
Journal:  Arch Microbiol       Date:  2007-10-06       Impact factor: 2.552

Review 9.  Role of Porphyromonas gingivalis HmuY in Immunopathogenesis of Chronic Periodontitis.

Authors:  P C Carvalho-Filho; I S Gomes-Filho; R Meyer; T Olczak; M T Xavier; S C Trindade
Journal:  Mediators Inflamm       Date:  2016-06-15       Impact factor: 4.711

10.  Unique structure and stability of HmuY, a novel heme-binding protein of Porphyromonas gingivalis.

Authors:  Halina Wójtowicz; Tibisay Guevara; Cynthia Tallant; Mariusz Olczak; Aneta Sroka; Jan Potempa; Maria Solà; Teresa Olczak; F Xavier Gomis-Rüth
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.